31 results
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
30 May 23
Tender offer solicitation (amended)
9:42pm
, the “Actions”), which generally seeks information in connection with a purported stockholder’s investigation of, among other things: (i) the events … generally seeks information in connection with a purported stockholder’s investigation of, among other things, (i) the events leading to the Offer, (ii
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
proceeds;
the results of the due diligence investigation that the Company’s senior management conducted with the assistance of its advisors on Parent … , to which the Company was or may have been a party or was or may have been subject, or of any governmental investigation of any possible unasserted
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
. As of the date of this Agreement, there is no Judgment outstanding against or, to the Knowledge of the Company, investigation by any Governmental … no, proceeding, action, notice, order of forfeiture or complaint, demand or investigation by or before any Governmental Entity pending
8-K
EX-1.1
STSA
Satsuma Pharmaceuticals Inc
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
pending or threatened claim, suit, proceeding, hearing, enforcement, investigation, arbitration or other action, from any court, arbitrator, governmental … to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in such debarment, suspension, or exclusion
8-K
EX-10.1
0zwn4ewckrdtj5w6 2z
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
S-3
EX-1.2
ils do5k0
23 Oct 20
Shelf registration
4:48pm
S-3
EX-4.4
y50lffhlgo 19kqhxe
23 Oct 20
Shelf registration
4:48pm
10-K
93bsmrq n99p1z
10 Mar 20
Annual report
4:20pm
10-Q
p5tq43v 6o
12 Nov 19
Quarterly report
4:31pm